Letters to the Editor

Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: real-world experience from a cancer center

Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York
Vol. 109 No. 7 (2024): July, 2024 https://doi.org/10.3324/haematol.2023.284565